 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The experts further advised to continue with the buy-on-dips strategy till the index holds 19,600-19,500 on the downside

Experts bet on these 10 stocks as raging bulls of D-St keep Nifty charged up

In the second quarter of FY24, the Pharma stocks saw strong revenue growth of 14.3% year-over-year and 1.7% quarter-over-quarter

Nifty Pharma scales record highs, rises in 14 out of 17 straight sessions

Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 417 in its research report dated November 09, 2023.

Buy Granules India; target of Rs 417 Sharekhan

Sobha formed robust bullish candlestick pattern on monthly charts, with making higher highs, higher lows formation for third consecutive month. The stock traded well above all key moving averages.

Trade Spotlight | How to deal in Sobha, JK Lakshmi Cement, Granules India today

The strength in bulls can be confirmed in case the Nifty goes above 19,450/19,460 levels, similarly for Bank Nifty the same can be seen above 44,000/44,100 zone.

Samvat 2080 | This technical chartist lists out 3 positional calls for Muhurat trading

The approval by the US Food &amp; Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules of strengths 20 mg and 40 mg, Granules India said in a regulatory filing.

Granules India gets USFDA nod for generic drug used for short-term treatment of heartburn

Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

Granules India gets USFDA approval for hypertension drug; share price gains

Granules India closed at 10-month high and  has seen a breakout of falling resistance trendline adjoining highs of December 23 last year and September 25 this year, and trading well above key moving averages.

Trade Spotlight | Your strategy for CE Info Systems, APL Apollo Tubes, Granules India

Going forward, 19,600-19,500 is expected to act as a crucial support for the Nifty50 in coming sessions, and if it manages to sustain above then the gradual upmove towards 20,000 can be possible, experts said

Top 10 bets for 3-4 weeks as bulls look tired at the peak, bears take over reins

For now, one needs to stay very selective with stock preferences and avoid being aggressive in the markets.

Hot Stocks | Here's why you should bet on Granules India, Bank of Baroda for short term

Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. It offers active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. The company was founded by Krishna Prasad Chigurupati on March 18, 1991 and is headquartered in Hyderabad, India.

Watchers	206
52-Wk Low	267.75
52-Wk High	404.90

Market Cap	95.76B
Volume (M)	1.15M
52-Wk High	404.90
52-Wk Low	267.75

GRANULES.NSE Granules India Ltd.

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community